Anthracyclines: — Side Effects and Heart Monitoring
Anthracyclines are one of the most widely used chemotherapy classes — given for breast cancer, lymphomas, leukaemias, sarcomas, and more. If your team has ordered an echocardiogram before you start, that is not a routine checkbox. It is the beginning of a monitoring plan that runs through your treatment.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026
- Used across many cancers — Anthracyclines appear in treatment plans for breast cancer, lymphoma, leukaemia, sarcoma, and several other diagnoses.
- The cardiac risk is cumulative — It is not a single cycle that creates risk but the total amount received across your full course.
- Two main formulations — Conventional anthracyclines and liposomal versions have meaningfully different side effect profiles.
- Monitoring is built into the plan — The echocardiogram before you start gives your team a baseline so any change in heart function can be detected early.
on Panel
Survival Rate*
Treated
(800+ reviews)
Anthracyclines — the class that includes doxorubicin and epirubicin — damage cancer cells by blocking the enzymes they use to copy their DNA. The main concern with this class is cumulative damage to the heart muscle. This is why your team orders an echocardiogram before you start and monitors your heart function during treatment.
Are all anthracyclines the same, or does the type make a difference?
| Feature | Conventional (e.g., doxorubicin, epirubicin) | Liposomal (e.g., Caelyx — pegylated liposomal doxorubicin) |
|---|---|---|
| How it is given | Short infusion | Slower infusion; rate is carefully controlled to reduce reactions |
| Cardiac risk | Dose-dependent; builds with cumulative exposure | Lower cardiac risk; often chosen when the heart is already a concern |
| Hair loss | Common | Less common than with conventional formulations |
| Nausea | Common; managed with anti-nausea medicines | Generally less severe |
| Hand-foot syndrome | Less common | More common; can affect palms and soles after several cycles |
| Infusion reactions | Uncommon | Can occur; managed by slowing the infusion rate |
| Heart monitoring | Echo before starting and at intervals during treatment | Also monitored, though the risk profile differs |
What does an anthracycline actually do inside the body?
Anthracyclines enter dividing cells and insert themselves into the strands of DNA, jamming an enzyme called topoisomerase II that the cell needs to copy its genetic material.
Without topoisomerase II working correctly, a cancer cell cannot divide and triggers its own death. This mechanism makes anthracyclines effective across many cancer types that divide rapidly.
The difficulty is that heart muscle cells also rely on topoisomerase II. Unlike most cells, heart muscle cells rarely regenerate. Damage to them accumulates rather than repairs itself — which is why the total amount received across your full course is tracked carefully.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
What do all these medical terms actually mean?
- Topoisomerase II
- An enzyme cancer cells need to copy their DNA. Anthracyclines block it, which stops the cell from dividing.
- Cumulative dose
- The total amount of anthracycline received across all your cycles. Cardiac risk is linked to this running total, not to any single infusion.
- Ejection fraction
- The proportion of blood your heart pumps out with each beat, measured by echocardiogram. Your pre-treatment figure is the baseline your team compares against during monitoring.
- Cardiomyopathy
- Weakening of the heart muscle. In the context of anthracyclines, this is the cardiac side effect that monitoring is designed to detect before it causes symptoms.
- Liposomal formulation
- A version of the medicine enclosed in a fat-based shell that changes where it concentrates in the body — reducing exposure to the heart compared with conventional formulations.
Why does the heart monitoring matter, and is the effect permanent?
The echocardiogram before your first cycle establishes your ejection fraction as a baseline. Without that number, any change mid-treatment has nothing meaningful to be compared against.
Caught early, a decline in heart function can be managed. Your oncologist and cardiologist can respond — sometimes by adjusting the treatment plan, sometimes by starting medicines that support the heart — before symptoms appear.
Whether the effect is permanent depends on when it is detected. Mild, early changes can sometimes recover partially or fully with time and cardiac support. More significant cardiomyopathy, if picked up late, is less likely to fully reverse. The monitoring is not a formality: it is the system that keeps the risk manageable.
If you have a pre-existing heart condition or high blood pressure, tell your team before your first echocardiogram. Your individual risk profile changes what the monitoring looks for.
Did you know?
Liposomal doxorubicin was developed specifically to reduce the cardiac toxicity of conventional doxorubicin. The fat-based shell changes where the medicine concentrates in the body, sparing the heart muscle while still reaching tumour tissue.
This is why two people with the same diagnosis may receive what sounds like the same drug and experience meaningfully different side effect profiles.
Source: ESMO Clinical Practice Guidelines — Cardiotoxicity of Anticancer Treatments
Explore 95 more Understanding Chemotherapy, Myths & Trials topics
Types & Classes of Chemotherapy
- Alkylating Agent Chemotherapy: What to Expect
- Anthracycline Chemotherapy: What to Expect
- Antimetabolite Chemotherapy: What to Expect
- Biosimilars in Cancer Treatment
- Can Your Chemotherapy Be Changed Partway Through?
- Generic vs Innovator Chemotherapy Drugs
- Growth Factor Injections After Chemotherapy
- Platinum-Based Chemotherapy: What to Expect
- Single-Agent vs Combination Chemotherapy
- Supportive Medicines Given With Chemotherapy
- Taxane Chemotherapy: What to Expect
- Topoisomerase Inhibitor Chemotherapy: What to Expect
- Types of Chemotherapy: The Main Classes Explained
- Vinca Alkaloid Chemotherapy: What to Expect
- What Is Dose-Dense Chemotherapy?
- What Is Metronomic Chemotherapy?
- What Is a Chemotherapy Regimen?
- Why Am I Given Steroids With Chemotherapy?
- Why the Class of Chemotherapy Decides Your Side Effects
Does Chemotherapy Work? Realistic Expectations
- Can Chemotherapy Be Avoided With a Genomic Test?
- Can Chemotherapy Cure Cancer?
- Can You Stop Chemotherapy Midway?
- Chemotherapy When You Are Already Very Unwell
- Chemotherapy or Surgery First: How Is It Decided?
- Do Worse Side Effects Mean It Is Working Better?
- Does Chemotherapy Actually Work?
- Does Everyone React the Same Way to Chemotherapy?
- Getting Palliative Care Alongside Chemotherapy
- How Will I Know It Is Working?
- Is Chemotherapy Worth the Side Effects?
- Is Palliative Chemotherapy Worth Having?
- Is There an Alternative to Chemotherapy?
- Reduced-Dose Chemotherapy: When Is It Offered?
- What Does Palliative Chemotherapy Mean?
- What If Chemotherapy Does Not Work?
HUB — Chemotherapy Myths and Alternative Treatment Claims
HUB — What Is Chemotherapy and Why Has It Been Advised?
Is This Chemotherapy? Hormone and Targeted Therapy
- Are EGFR Tablets Like Gefitinib Chemotherapy?
- Are Steroids Chemotherapy?
- Chemotherapy vs Hormone Therapy
- Chemotherapy vs Immunotherapy
- Chemotherapy vs Targeted Therapy
- Do You Lose Your Hair on Every Cancer Medicine?
- Is Capecitabine Chemotherapy? Yes, and Why It Matters
- Is Every Cancer Medicine Chemotherapy?
- Is Imatinib Chemotherapy?
- Is Letrozole or Anastrozole Chemotherapy?
- Is Tamoxifen Chemotherapy?
- Which Precautions Apply to Which Treatment?
Myths & Alternative Treatment Claims
- Can Ayurveda Treat Cancer Instead of Chemotherapy?
- Can You Use Traditional Medicine Alongside Chemotherapy?
- Cannabis Oil and Cancer Treatment Claims
- Chemotherapy Myths in Telugu Households
- Do Cow Urine, Wheatgrass and Home Remedies Treat Cancer?
- Does Chemotherapy Kill You? The Evidence
- Homeopathy and Cancer Treatment Claims
- How to Spot a Fake Cancer Cure
- Is Chemotherapy Worse Than the Cancer?
- Myth: Chemotherapy Destroys Your Immunity Forever
- Myth: Chemotherapy Is Contagious or Dangerous to Others
- Myth: Chemotherapy Is Just a Money-Making Business
- Myth: Chemotherapy Means the Cancer Is Terminal
- Myth: Chemotherapy Patients Must Be Isolated
- Myth: Chemotherapy Spreads Cancer or Causes New Cancers
- Myth: Everyone Loses All Their Hair
- Myth: Once You Start Chemotherapy You Cannot Stop
- Myth: You Cannot Eat Anything During Chemotherapy
- Naturopathy, Detox and Alkaline Diet Claims
- Talking to a Family Member Who Refuses Chemotherapy
- What Happens If You Refuse Chemotherapy?
- Why Do People Believe Chemotherapy Does Not Work?
Understanding Chemotherapy & Why It Is Advised
- Can Chemotherapy Be Refused or Delayed?
- Can I Get a Second Opinion Before Starting?
- Chemotherapy After Surgery: Why It Is Needed
- Chemotherapy Before Surgery: Why It Is Given First
- Chemotherapy Terminology: A Plain-English Glossary
- Chemotherapy for a Cancer That Has Come Back
- Chemotherapy in a Clinical Trial
- Chemotherapy vs Targeted Therapy vs Immunotherapy
- Consent for Chemotherapy: What You Are Signing
- Curative, Adjuvant, Neoadjuvant and Palliative: What Your Intent Means
- Does Chemotherapy Mean My Cancer Is Advanced?
- How Long Does a Course of Chemotherapy Last?
- How Many Cycles of Chemotherapy Will I Need?
- Is Chemotherapy Painful?
- Questions to Ask Before Starting Chemotherapy
- What Chemotherapy Cannot Do
- What Happens Inside Your Body During Chemotherapy?
- What Is Chemoradiation?
- What Is Chemotherapy and How Does It Work?
- What Is Maintenance Chemotherapy?
- Who Decides Your Chemotherapy Plan?
- Why Has Chemotherapy Been Advised for Me?
- Why Is Chemotherapy Given in Cycles?
- Your Chemotherapy Plan Sheet: How to Read It
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Frequently asked questions
Will I definitely have heart problems on anthracyclines?
No — most people who receive anthracyclines do not develop significant heart problems. The risk is real but it is not inevitable, and it rises gradually with cumulative exposure rather than appearing suddenly. Your team tracks the total amount you receive and checks your echocardiogram precisely because early cardiac changes can usually be identified and managed before they cause any symptoms. Factors that affect your individual risk include pre-existing heart disease, high blood pressure, and whether you have had radiation to the chest previously.
Why do I need an echocardiogram before I even start?
The pre-treatment echo establishes your ejection fraction — the proportion of blood your heart pumps per beat — as a personal baseline. Without it, a result mid-treatment that looks borderline has nothing to be compared against. Your team cannot tell whether it represents a significant drop or no real change unless they know where you started. The echo before your first cycle is the most important one in the whole monitoring sequence.
What is the difference between doxorubicin and Caelyx?
Both contain the same active molecule. Caelyx is the pegylated liposomal version, meaning the doxorubicin is enclosed in a fat-based shell that alters where it concentrates in the body. Liposomal formulations carry a lower cardiac risk and cause less hair loss, but a higher rate of hand-foot syndrome — a skin reaction on the palms and soles. The choice between formulations is a clinical decision based on your cardiac history, your diagnosis, and how treatment is being used overall. Ask your oncologist to explain why a specific formulation was chosen for you.
How long after finishing chemotherapy can heart problems appear?
This is one of the features that makes anthracycline-related cardiomyopathy distinct from most chemotherapy side effects. It can appear during treatment, in the months immediately after finishing, or years later — particularly in people treated in childhood or who received higher cumulative doses. Long-term cardiac follow-up is recommended by ESMO and ASCO for people who received significant cumulative exposure. If you were treated some years ago and have not had a cardiac review, ask your oncologist or GP whether one is appropriate.
Can I take something to protect my heart during anthracycline treatment?
Some medicines have been studied for cardiac protection during anthracycline chemotherapy, and this is a decision your oncologist and cardiologist make together based on your individual risk profile. Do not start any supplement or preparation for heart protection without discussing it with your team first. Certain herbal preparations interact with chemotherapy in ways that are not yet fully understood, and some antioxidants may affect how the treatment works. If you are concerned about your cardiac risk, ask for a cardio-oncology review before treatment begins.
Are there situations where anthracyclines would not be used because of the cardiac risk?
Yes. For some people — those with significantly reduced heart function at baseline, a recent heart attack, or severe pre-existing cardiac disease — an anthracycline may not be the safest choice even when it would normally be part of standard treatment. In those situations your oncologist considers alternatives and weighs the risk of a less effective treatment against the cardiac risk of proceeding. This decision is made individually, not by formula, and you are entitled to ask your oncologist to walk you through their reasoning.
Chemotherapy Topics
Browse our complete chemotherapy guide — 1133 pages on side effects, medicines, cost, daily life and care in Hyderabad. Tap any topic to read more.